Quadrant Capital Group LLC Acadia Pharmaceuticals Inc Transaction History
Quadrant Capital Group LLC
- $1.42 Billion
- Q3 2024
A detailed history of Quadrant Capital Group LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 205 shares of ACAD stock, worth $3,839. This represents 0.0% of its overall portfolio holdings.
Number of Shares
205Holding current value
$3,839% of portfolio
0.0%Shares
14 transactions
Others Institutions Holding ACAD
# of Institutions
284Shares Held
158MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$803 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$259 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$257 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$226 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$112 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.03B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...